Client Partner, MedTech Engineering Services
Technology
Job Description
About the role
\n
You will own new-logo acquisition and existing account growth for Onward Tech's engineering-services portfolio across growth-stage and mid-market MedTech firms in the Midwest. This is a consultative, solution-led sale - not transactional.
\n
What you'll sell
\n
- \n
- AI Projects: ML model development, GenAI and LLM applications, computer vision for imaging and diagnostics, and predictive analytics, including AI-enabled SaMD taken from proof-of-concept through validated, regulatory-ready deployment
- Digital Engineering: DevOps, data engineering, data analytics, QA & test automation, cloud (AWS/Azure/GCP), product engineering, SaMD development
- Regulatory Assurance: FDA 510(k) support, EU MDR/IVDR compliance, DHF management, IEC 62304, CSV/CSA, post-market surveillance, CAPA automation
- Manufacturing Engineering: Production and process engineering, design-for-manufacturability, tooling and fixture design, automation and equipment engineering, and manufacturing/test support for medical device.
\n
\n
\n
\n
\n
Key responsibilities
\n
- \n
- Work a named-account list of MedTech and digital health companies with an ABM-led approach
- Run consultative, CTO/VP-level conversations that translate engineering and regulatory pain into scoped engagements
- Build and manage pipeline in CRM; forecast accurately against revenue and pipeline targets
- Partner with delivery leadership on solutioning, proposals, and senior-led delivery reviews
- Represent Onward at industry events and contribute to whitepapers and case studies
\n
\n
\n
\n
\n
\n
What you bring
\n
- \n
- 8+ years selling engineering, product-development, or regulatory/quality services into medical device, MedTech, or life-sciences companies
- Fluency talking to technical buyers (Engineering Leaders, Quality/Regulatory Leaders) and translating between engineering and commercial value
- Working understanding of the medical-device regulatory landscape (FDA, EU MDR/IVDR, IEC 62304)
- Comfort selling a dual-shore/offshore delivery model and defending it on quality, speed, and cost.
- Established Midwest network in MedTech / life sciences is a strong plus.
\n
\n
\n
\n
\n
\n
How success is measured
\n
- \n
- Qualified pipeline generated and revenue closed.
- New logos landed and named accounts penetrated.
\n
\n